Aphexda
NDC 82737-073, Motixafortide, injection, powder, lyophilized, for solution, from BioLineRx USA Inc.
- Product NDC
- 82737-073
- Status
- Listed
- Labeler
- BioLineRx USA Inc
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA217159
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/82737-073 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MOTIXAFORTIDE ACETATE62 mg/1.7mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 82737-073-01 | 82737007301 | 1 VIAL, GLASS in 1 CARTON (82737-073-01) / 1.7 mL in 1 VIAL, GLASS |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/f7cdc584-ebf0-a68e-e053-6294a90a9ea9Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=82737-073
Use it
Look up 82737-073 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/82737-073 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 82737-073. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.